etoposide has been researched along with Endometrial Neoplasms in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (46.15) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CA; Chen, YL; Cheng, WF; Lin, MC; Tu, YA | 1 |
| Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T | 1 |
| Bradford, AP; Haughian, JM; Jackson, TA; Reno, EM; Thorne, AM | 1 |
| Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y | 1 |
| Bai, T; Tanaka, T; Yukawa, K | 1 |
| Bernardini, MG; Calvieri, G; Lo Voi, R; Rossi, R; Stacchiotti, D | 1 |
| Godoy, HE; Lele, SB; Odunsi, K; Olawaiye, AB; Rauh-Hain, JA; Shahzad, MM | 1 |
| Bilgin, T; Kara, HF; Ozan, H | 1 |
| Abadie-Lacourtoisie, S; Catala, L; Descamps, P; Lortholary, A; Morand, C; Paillocher, N; Verriele, V | 1 |
| Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K; Ojima, Y; Seki, N | 1 |
| Bradford, AP; Haughian, JM; Jackson, TA; Koterwas, DM | 1 |
| Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS | 1 |
| Carrasco, CH; Collier, RE; Delclos, L; Kavanagh, JJ; Kudelka, AP; Lawrence, DD; Lin, YC; Malpica, A; Munoz, A; Tresukosol, D | 1 |
| Adel, AL; Dorr, RT; Liddil, JD | 1 |
| Fujita, H; Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T; Yasuda, J | 2 |
| Neijt, JP | 1 |
| Beuzeboc, P; Dieras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangie, T; Paraiso, D; Pierga, JY; Pouillart, P; Scholl, SM | 1 |
| Blessing, JA; Creasman, WT; Lewandowski, GS; Rose, PG; Webster, KD | 1 |
| Beuzeboc, P; Diéras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangié, T; Pierga, JY; Pouillart, P; Scholl, SM | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
| Aebi, S; Fink, D; Fink, JL; Gordon, R; Howell, SB; Kim, HK; Zheng, H | 1 |
| Alberts, DS; Delmore, JE; Fine, BA; Hannigan, EV; Liu, PY; Moore, DF; Poplin, EA; Potkul, RK; Wilczynski, S | 1 |
| Bilgrami, S; Bona, RD; Edwards, RL; Feingold, JM; Kapur, D; Khan, AM; Rodriguez-Pinero, F; Tutschka, PJ | 1 |
| Miyama, M; Ogita, S; Tanaka, T; Umesaki, N | 1 |
| Fujimura, H; Kikkawa, F; Mizutani, S; Nakashima, N; Oguchi, H | 1 |
4 review(s) available for etoposide and Endometrial Neoplasms
| Article | Year |
|---|---|
Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Etoposide; Female; Humans; Middle Aged; Salvage Therapy | 2018 |
Primary yolk sac tumor of the endometrium: a case report and review of the literature.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Chemotherapy, Adjuvant; Cisplatin; Endodermal Sinus Tumor; Endometrial Neoplasms; Etoposide; Female; Humans; Hysterectomy; Uterine Hemorrhage | 2011 |
[Low-grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide].
Topics: Antineoplastic Agents, Phytogenic; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Pregnancy; Progestins; Sarcoma | 2005 |
Advances in the chemotherapy of gynecologic cancer.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Endometrial Neoplasms; Etoposide; Female; Genital Neoplasms, Female; Germinoma; Humans; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Cervical Neoplasms | 1994 |
9 trial(s) available for etoposide and Endometrial Neoplasms
| Article | Year |
|---|---|
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate | 2013 |
Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Treatment Outcome; Uterus | 2007 |
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate | 1995 |
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1996 |
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Administration, Oral; Cohort Studies; Endometrial Neoplasms; Etoposide; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Thrombocytopenia; Time Factors | 1996 |
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1997 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Adjuvant chemotherapy including cisplatin in endometrial carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Survival Rate; Treatment Outcome | 2000 |
13 other study(ies) available for etoposide and Endometrial Neoplasms
| Article | Year |
|---|---|
c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; DNA Damage; Endometrial Neoplasms; Enzyme Activation; Etoposide; Extracellular Signal-Regulated MAP Kinases; Female; Gene Knockdown Techniques; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mutant Proteins; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Ultraviolet Rays | 2009 |
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Young Adult | 2010 |
Suppressed protein expression of the death-associated protein kinase enhances 5-fluorouracil-sensitivity but not etoposide-sensitivity in human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Death-Associated Protein Kinases; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Gene Knockdown Techniques; Humans; RNA, Small Interfering; Transfection | 2010 |
Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel | 2012 |
Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Medical Records; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2004 |
Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Endometrial Neoplasms; Etoposide; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Poly(ADP-ribose) Polymerases; Protein Kinase C-alpha; Protein Kinase C-delta; Subcellular Fractions; Tumor Cells, Cultured | 2006 |
Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy.
Topics: Administration, Oral; Combined Modality Therapy; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Salvage Therapy; Sarcoma, Endometrial Stromal | 1995 |
The effect of anticancer drug sequence in experimental combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Survival; Cisplatin; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Kinetics; Mitomycin; Multiple Myeloma; Tumor Cells, Cultured | 1993 |
[Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
Topics: Adenocarcinoma; Administration, Oral; Aged; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local | 1995 |
[Estimation of medroxyprogesterone acetate (MPA) and etoposide against a human uterine endometrial cancer].
Topics: Animals; Cell Division; Drug Synergism; Endometrial Neoplasms; Etoposide; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Nude; Subrenal Capsule Assay; Tetrazolium Salts; Thiazoles | 1994 |
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carrier Proteins; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Adducts; DNA Damage; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methylnitronitrosoguanidine; Mutagenesis; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Thioguanine; Tumor Cells, Cultured | 1997 |
A novel combination of paclitaxel, etoposide, and cyclophosphamide for stem cell mobilization and tumor cytoreduction in ovarian cancer.
Topics: Alopecia; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carcinoma, Papillary; Cyclophosphamide; Endometrial Neoplasms; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Klebsiella Infections; Leukapheresis; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Serous Membrane; Taxoids | 2000 |
Effect of adjuvant chemotherapy using pirarubicin, cisplatin, and etoposide (PEP) for stage IVB endometrial carcinoma: a case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging | 2000 |